Clinical Trial Update: Bevacizumab in Treating Patients With Recurrent or Progressive Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating bevacizumab for recurrent or progressive glioma has completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2012-11-19